DexCom, Inc. vs Johnson & Johnson — Stock Comparison

DXCM
DexCom, Inc.
$61.35
▲ 3.02%
vs
JNJ
Johnson & Johnson
$227.19
▼ 1.16%
Q·Score Winner
DexCom, Inc.
DXCM8.8/10vs 7.1/10

Q·Score Breakdown

8.8
Very Bullish
Overall
7.1
Bullish
8.5
Quality
9.3
9.1
Health
6.5
8.9
Growth
5.1
9.2
Valuation
7.3
8.4
Sentiment
6.5
DXCM

Consensus analyst target of $83.92 is 37% above current price.

JNJ

High-quality business with 26% return on equity and 22% profit margins.

earnings contracting 53% year-over-year.

Analyst Consensus

BUY
Target $83.92 (+36.8%)
24 analysts
BUY
Target $252.42 (+11.1%)
24 analysts

Fundamentals

DXCM
JNJ
26.3×
Trailing P/E
26.3×
20.1×
Forward P/E
17.9×
19.3%
Profit Margin
21.8%
61.5%
Gross Margin
68.0%
35.6%
ROE
26.4%
15.0%
Revenue Growth
9.9%
91.9%
Earnings Growth
-52.9%
Beta
0.33
Price / Book
$23.7B
Market Cap
$546.9B
$54 – $90
52-Week Range
$146 – $252

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →